Stefan Dyckerhoff Sells 8,994 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the sale, the director directly owned 4,631 shares of the company’s stock, valued at $2,083,950. This trade represents a 66.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Stock Performance

Shares of NASDAQ ALAB traded down $24.44 during mid-day trading on Thursday, reaching $406.42. The company had a trading volume of 7,173,307 shares, compared to its average volume of 6,270,830. Astera Labs, Inc. has a twelve month low of $88.18 and a twelve month high of $499.48. The stock has a market capitalization of $69.66 billion, a PE ratio of 319.16, a price-to-earnings-growth ratio of 4.94 and a beta of 3.66. The stock’s 50 day moving average is $306.18 and its 200-day moving average is $202.33.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same period last year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on ALAB shares. Roth Mkm reiterated a “buy” rating and set a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Susquehanna raised their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Jefferies Financial Group reiterated a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Evercore reissued an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Finally, Citigroup lowered shares of Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $265.75.

Institutional Investors Weigh In On Astera Labs

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Royal Bank of Canada lifted its stake in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares during the last quarter. AQR Capital Management LLC raised its holdings in Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after acquiring an additional 7,756 shares during the period. Empowered Funds LLC lifted its position in Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after acquiring an additional 4,183 shares during the last quarter. First Trust Advisors LP lifted its position in Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after acquiring an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. boosted its holdings in Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.